An engineered monomer binding-protein for α-synuclein efficiently inhibits the proliferation of amyloid fibrils
Removing or preventing the formation of [Formula: see text]-synuclein aggregates is a plausible strategy against Parkinson’s disease. To this end, we have engineered the [Formula: see text]-wrapin AS69 to bind monomeric [Formula: see text]-synuclein with high affinity. In cultured cells, AS69 reduce...
Κύριοι συγγραφείς: | , , , , , , , , , , , , , |
---|---|
Μορφή: | Άρθρο |
Γλώσσα: | English |
Έκδοση: |
eLife Sciences Publications Ltd
2019-08-01
|
Σειρά: | eLife |
Θέματα: | |
Διαθέσιμο Online: | https://elifesciences.org/articles/46112 |